Facebook Linkedin Mail Twitter Youtube
Facebook Linkedin Mail Twitter Youtube

Tag: semaglutide

STRIDE trial analysis confirms potential impact of semaglutide on quality-of-life metrics...

The findings of a new analysis from the STRIDE trial, presented at the American Diabetes Association (ADA) 2025 scientific session (20–23 June, Chicago, USA)...
Vascular News

Write to us
Editor: Jocelyn Hudson [email protected]
Vascular News Advertising: Rav Pankhania [email protected]


United Kingdom:

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: [email protected]

United States:

BIBA Medical, North America
155 North Wacker Drive, Suite 4250, Chicago, IL 60606
TEL: +1 949 723 9309
Email: [email protected]

Terms and Conditions | Privacy Policy

Facebook Linkedin Mail Twitter Youtube